CONTINUE TO SITE
OR WAIT 15 SECS
Japan-based Astellas Pharma Inc. has agreed on a Memorandum of Understanding (MoU) with the Korea Institu
Novo Nordisk has signed a Memorandum of Understanding (MoU) with TEDA Administrative Commission, agreeing to i
Japan's JCR Pharmaceuticals Co. has entered into a license agreement with Alexion, AstraZeneca Rare Disease, f
The Department of Health – Abu Dhabi (DoH), the regulator of the healthcare sector in the Emir
SK bioscience, a global innovative vaccine and biotech company based in South Korea, has secured a larg
A research team led by Dr Der-Yang Cho, Superintendent of China Medical University Hospital (Taiwan), in colla
DeepQure has announced that South Korea's Ministry of Food and Drug Safety (MFDS) has approved a clinical tria
Inocras Inc., a global leader in whole-genome sequencing (WGS) and bioinformatics, has announced the signing o
WuXi Biologics, a leading global Contract Research, Development, and Manufacturing Organisation (CRDMO) in Chi
Vetter, a globally operating Contract Development and Manufacturing Organisation (CDMO), recently celebrated t
Medical Advances Soar With APAC’S CLINICAL TRIAL GROWTH
It’s a truth universally acknowledged that Asia-Pacific is a hotbed for clinical trials, with multiple reports confirming that it is the only region in the world to have seen a consistent surge in clinical trial activity. The Asia Pacific clinical trials market generated a revenue of $15.91 billion in 2023 and is expected to reach a projected revenue of $25.99 billion by 2030 at a compound annual growth rate of 7.3 per cent, according to the Grand View Research report. Between 2020 and 2025, China, India, Australia, Japan, South Korea, and Singapore emerged as key pillars of Asia-Pacific’s growing clinical trial ecosystem. Together, these six countries accounted for nearly 40,000 trials (39,843 in total). We take a close look at each country’s clinical trial landscape, examining who is leading in which phases, how domestic players compare to multinational sponsors, and which therapeutic areas are seeing the most activity. We also explore the challenges of running trials across such a diverse region.
Bioprocessing Summit 2025
CHI
chi@healthtech.com https://www.bioprocessingsummit.com/?_gl=1*fixkm7*corpRollup_au*MTk3NzMzODI2OS4xNzM0Njg5OTYz*corpRollup_ga*MTkwMDU1MTk4OS4xNzM0Njg5OTYz*corpRollup_ga_2EH9C0L8YB*MTczNTE5ODI4Ni4zLjAuMTczNTE5ODMwMi40NC4wLjA.&instrck=eyJhIjoiNjJkYzc3YjUtOWZiYy03NGM2LThmNzktZDA1NDYzZjA1NjVlIiwicyI6IjE3MzQ2OTAxNjI1NjgtNTdjMDc2NzAtOWJlOC00NWFiLTllM2ItM2YzNzM3NjgyODYxIiwiZCI6IkNJSV9ERUMiLCJ0IjoxNzM1MTk4MzA1ODI1LCJzaSI6IjE3MzUxOTgyOTU1NjQtYzg2NWU5OWYtNmM0MS00NTEzLTkyZjEtNzIxNDkxNTA1ZDU1In0=Boston
7th Macrophage-directed Therapies Summit 2025
Hanson Wade
info@hansonwade.com https://macrophage-directed-therapies.com/Boston
2nd Lab Ops & Facility Management for Biopharma
Hanson Wade
info@hansonwade.com https://lab-ops-for-biopharma.com/Boston
